Celularity Inc. Earnings Per Share (Basic)
Celularity Inc. (CELU) reported Earnings Per Share (Basic) of -$3.59 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-04-30
- Celularity Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.86.
- Celularity Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.88.
- Celularity Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$1.02.
- Celularity Inc. earnings per share, basic for the quarter ending 2025-03-31 was -$0.84.
- Celularity Inc. earnings per share, basic for fiscal 2025 was -$3.59.
- Celularity Inc. earnings per share, basic for fiscal 2024 was -$2.64.
- Celularity Inc. earnings per share, basic for fiscal 2023 was -$11.02, a 1191.09% decline from fiscal 2022.
- Celularity Inc. earnings per share, basic for fiscal 2022 was $1.01.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.73 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.74 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$3.59 10-K · filed 2026-04-30 | ||||
| 2025-09-30 | -$0.88 10-Q · filed 2025-11-14 | -$1.89 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$2.74 10-Q · filed 2025-11-14 | -$3.36 derived: net income ÷ weighted average shares · filed 2026-04-30 | ||||
| 2025-06-30 | -$1.02 10-Q · filed 2025-08-29 | -$1.86 10-Q · filed 2025-08-29 | -$2.48 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$3.21 derived: net income ÷ weighted average shares · filed 2026-04-30 | ||||
| 2025-03-31 | -$0.84 10-Q · filed 2025-08-29 | -$1.44 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.18 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.48 derived: net income ÷ weighted average shares · filed 2026-04-30 | ||||
| 2024-12-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.33 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.64 10-K · filed 2026-04-30 | ||||
| 2024-09-30 | -$0.73 10-Q · filed 2025-11-14 | -$1.03 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$2.05 10-Q · filed 2025-11-14 | |||||
| 2024-06-30 | -$0.30 10-Q · filed 2025-08-29 | -$1.32 10-Q · filed 2025-08-29 | ||||||
| 2024-03-31 | -$1.03 10-Q · filed 2025-08-29 | |||||||
| 2023-12-31 | -$11.02 10-K · filed 2025-05-08 | |||||||
| 2023-09-30 | -$4.98 10-Q · filed 2024-12-06 | -$0.50 10-Q · filed 2024-01-03 | -$11.86 10-Q · filed 2024-12-06 | -$1.19 10-Q · filed 2024-01-03 | ||||
| 2023-06-30 | -$2.72 10-Q · filed 2024-11-07 | -$0.27 10-Q · filed 2023-08-14 | -$6.74 10-Q · filed 2024-11-07 | -$0.67 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$4.12 10-Q · filed 2024-10-16 | -$0.41 10-Q · filed 2023-05-22 | ||||||
| 2022-12-31 | $1.01 10-K · filed 2024-07-30 | $0.10 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | $0.03 10-Q · filed 2024-01-03 | -$0.07 10-Q · filed 2024-01-03 | ||||||
| 2022-06-30 | $0.34 10-Q · filed 2023-08-14 | -$0.11 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$0.48 10-Q · filed 2023-05-22 | |||||||
| 2021-12-31 | -$1.49 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | $0.47 10-Q · filed 2022-11-10 | -$2.00 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | -$2.69 10-Q · filed 2022-08-09 | -$6.09 10-Q · filed 2022-08-09 | ||||||
| 2020-09-30 | -$2.52 10-Q · filed 2021-11-12 | -$11.52 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |